Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company based in Chatham, New Jersey, focused on developing innovative therapies for central nervous system disorders and rare diseases. The company is committed to advancing its proprietary drug candidates through clinical development, with a particular emphasis on addressing unmet medical needs in mental health and pain management. Tonix's strategic pipeline aims to leverage its expertise in drug formulation and delivery, positioning the company for potential growth and expansion within the pharmaceutical sector.